Sixty-four patients with ischemic heart disease treated with simvastatin 20mg who had not achieved the
therapeutic targetwere enrolled. Patients were randomised 1:1. Patients of group A (n=32) were given simvastatin
40 mg per day and patients of group B (n =32) were given simvastatin 20 mg plus 2 tablets of a nutraceutical
composed of bergamot, phytosterols, artichoke, vitamin C.